Cargando…
The kinase polypharmacology landscape of clinical PARP inhibitors
Polypharmacology plays an important role in defining response and adverse effects of drugs. For some mechanisms, experimentally mapping polypharmacology is commonplace, although this is typically done within the same protein class. Four PARP inhibitors have been approved by the FDA as cancer therape...
Autores principales: | Antolin, Albert A., Ameratunga, Malaka, Banerji, Udai, Clarke, Paul A., Workman, Paul, Al-Lazikani, Bissan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026418/ https://www.ncbi.nlm.nih.gov/pubmed/32066817 http://dx.doi.org/10.1038/s41598-020-59074-4 |
Ejemplares similares
-
Evolution of kinase polypharmacology across HSP90 drug discovery
por: Antolin, Albert A., et al.
Publicado: (2021) -
Polypharmacology in Precision Oncology: Current Applications and Future
Prospects
por: Antolin, Albert A., et al.
Publicado: (2016) -
Blocking the survival of the nastiest by HSP90 inhibition
por: Workman, Paul, et al.
Publicado: (2016) -
Objective, Quantitative, Data-Driven Assessment of Chemical Probes
por: Antolin, Albert A., et al.
Publicado: (2018) -
SiGNet: A signaling network data simulator to enable signaling network inference
por: Coker, Elizabeth A., et al.
Publicado: (2017)